Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-tumor Activity of Ascending Doses of ARN 509 in Combination With Abiraterone Acetate
Clinical trial NCT01792687 · COMPLETED
Trial details
- NCT number
- NCT01792687
- Sponsor
- Aragon Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-05
- Primary completion
- 2014-05-10
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.